{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:44:31Z","timestamp":1778892271799,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.burns.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:44:20Z","timestamp":1687959860000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine"],"prefix":"10.1016","volume":"50","author":[{"given":"Edward A.","family":"Stanley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-9467","authenticated-orcid":false,"given":"Lois","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Haertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Maitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2023.06.016_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2022.4543","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome\/toxic epidermal necrolysis: summary of a cochrane review","author":"Noe","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2023.06.016_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2023.06.016_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.burns.2023.06.016_bib4","series-title":"Fitzpatrick's Dermatology, 9e","article-title":"Epidermal Necrolysis (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis)","author":"Mockenhaupt","year":"2019"},{"issue":"4","key":"10.1016\/j.burns.2023.06.016_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.dsi.2013.09.002","article-title":"Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"31","author":"Su","year":"2013","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.burns.2023.06.016_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/biomedicines10092105","article-title":"A review of the systemic treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"10","author":"Chang","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.burns.2023.06.016_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/toxins6010194","article-title":"Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions","volume":"6","author":"Su","year":"2014","journal-title":"Toxins (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.burns.2023.06.016_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08820538.2015.1115255","article-title":"Immunologic mediators in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"31","author":"Saeed","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"12","key":"10.1016\/j.burns.2023.06.016_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.burns.2023.06.016_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.jid.5700648","article-title":"Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas","volume":"127","author":"Stur","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"7807","key":"10.1016\/j.burns.2023.06.016_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.burns.2023.06.016_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37257","article-title":"Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis","volume":"4","author":"Ma","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.burns.2023.06.016_bib13","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1038\/s41598-021-83550-0","article-title":"Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis","volume":"11","author":"Barcelos","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.burns.2023.06.016_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ced.14574","article-title":"COVID-19-induced toxic epidermal necrolysis","volume":"46","author":"Narang","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2023.06.016_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4997\/jrcpe.2021.214","article-title":"Case of erythema multiforme\/Stevens\u2013Johnson syndrome: an unusual presentation of Covid-19","volume":"51","author":"Abdelgabar","year":"2021","journal-title":"J R Coll Physicians Edinb"},{"issue":"1","key":"10.1016\/j.burns.2023.06.016_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12886-021-02033-y","article-title":"Corona virus disease 2019-associated Stevens-Johnson syndrome: a case report","volume":"21","author":"Shahraki","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.burns.2023.06.016_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.15753","article-title":"Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA","volume":"48","author":"Tanaka","year":"2021","journal-title":"J Dermatol"},{"issue":"e2","key":"10.1016\/j.burns.2023.06.016_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/postgradmedj-2021-140778","article-title":"Stevens-Johnson syndrome as a primary skin manifestation of COVID-19","volume":"98","author":"Muhd Besari","year":"2022","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.burns.2023.06.016_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.burns.2023.06.016_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2005-07-2702","article-title":"Epstein-Barr virus: the impact of scientific advances on clinical practice","volume":"107","author":"Williams","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.burns.2023.06.016_bib21","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/art.10564","article-title":"Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis","volume":"46","author":"Massa","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.burns.2023.06.016_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-5699(98)01429-7","article-title":"The influence of antiviral T-cell responses on the alloreactive repertoire","volume":"20","author":"Burrows","year":"1999","journal-title":"Immunol Today"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417923001286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417923001286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T08:22:16Z","timestamp":1759652536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417923001286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0305417923001286"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2023.06.016","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}